TGFB3 Mouse

Transforming Growth Factor-Beta 3 Mouse Recombinant
Cat. No.
BT5272
Source
Escherichia Coli.
Synonyms
Transforming Growth Factor-beta3, TGFB3, ARVD, FLJ16571, TGF-beta3.
Appearance
Sterile Filtered clear solution.
Purity

Greater than 95.0% as determined by SDS-PAGE.

Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TGF-β 3 Mouse Recombinant produced in E.Coli is a disulfide-linked homodimeric, non-glycosylated, polypeptide chain containing two 113 amino acid chains and having a total molecular mass of 25.7kDa.

The TGF-β 3 is purified by standard chromatographic techniques.

Product Specs

Introduction
There are three known mammalian isoforms of Transforming growth factor betas (TGF Betas), which are involved in numerous cell-to-cell interactions during embryonic development. These isoforms, TGF Beta 1, TGF Beta 2, and TGF Beta 3, are synthesized as precursor proteins with a similar structure. Each precursor protein undergoes cleavage to produce a 112 amino acid polypeptide that remains linked to the latent part of the molecule.
Description

Recombinant Mouse TGF-β3, produced in E. coli, is a non-glycosylated, homodimeric polypeptide chain connected by disulfide bonds. It comprises two chains of 113 amino acids, resulting in a total molecular weight of 25.7 kDa.

Purification of TGF-β3 is achieved through standard chromatographic methods.

Physical Appearance
A clear solution that has been sterilized by filtration.
Formulation

The solution containing the Mouse TGFB3 protein is prepared with 20% Ethanol and 10mM Acetic acid.

Stability
While Mouse TGF-beta 3 remains stable at room temperature for a period of 3 weeks, it is recommended to store it at 4°C. For extended storage, adding a carrier protein (0.1% HSA or BSA) is advisable.
Purity

SDS-PAGE analysis indicates a purity greater than 95.0%.

Biological Activity
The ability of the protein to induce chondrogenic differentiation serves as a measure of its activity.
Protein Content
Protein quantification was performed using two separate methodologies:
1. UV spectroscopy at 280 nm, employing an absorbance value of 1.718 as the extinction coefficient for a 0.1% (1 mg/ml) solution. This value is derived from the analysis of protein sequences using the PC GENE computer program (IntelliGenetics).
2. Analysis by RP-HPLC, utilizing a calibrated solution of TGF-b 3 as a reference standard.
Synonyms
Transforming Growth Factor-beta3, TGFB3, ARVD, FLJ16571, TGF-beta3.
Source
Escherichia Coli.
Amino Acid Sequence

MALDTNYCFRN LEENCCVRPL YIDFRQDLGW KWVHEPKGYY ANFCSGPCPY LRSADTTHST VLGLYNTLNP EASASPCCVP QDLEPLTILY YVGRTPKVEQ LSNMVVKSCK CS.

Product Science Overview

Structure and Expression

Recombinant mouse TGF-β3 is a non-glycosylated, disulfide-linked homodimer, consisting of two 112 amino acid chains, with a total molecular weight of approximately 25.5 kDa . The protein is expressed in various tissues and plays a crucial role in cellular adhesion and extracellular matrix (ECM) formation .

Mechanism of Action

TGF-β3 binds to serine-threonine kinase type I and II receptors on the cell surface, initiating a signal transduction cascade through SMAD2/3 proteins . This signaling pathway regulates a variety of cellular functions, including:

  • Cell Proliferation: Promotes or inhibits cell division depending on the cellular context.
  • Differentiation: Guides stem cells to develop into specific cell types.
  • Wound Healing: Enhances glycosaminoglycan production by mesenchymal stromal cells and stimulates scar-free healing .
  • Apoptosis: Induces programmed cell death in certain conditions .
Biological Functions

TGF-β3 is involved in several critical biological processes:

  • Embryogenesis and Development: Essential for palate development and lung formation in mammals .
  • Wound Healing: Regulates the movement of epidermal and dermal cells during skin injury repair .
  • Metabolism: Improves glucose tolerance and induces phenotypic changes in adipocyte morphology .
Clinical Research and Applications

Recombinant TGF-β3 has been studied for its potential therapeutic applications. For instance, it has been investigated for its role in promoting scar-free healing and improving glucose tolerance . However, clinical trials have shown mixed results, with some promising outcomes in early-phase trials but failures in later phases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.